313: Long-Term Survival of Patients with Metastatic Transitional Cell Carcinoma Treated with a Combined-Modality Approach of Chemotherapy and Metastasectomy
Le résumé fourni par la source
You have accessJournal of UrologyDiscussed Poster, Sunday, May 9, 2004, 8:00 am - 12:00 pm1 Apr 2004313: Long-Term Survival of Patients with Metastatic Transitional Cell Carcinoma Treated with a Combined-Modality Approach of Chemotherapy and Metastasectomy Markus Hack, Martin Gerber, Olaf Dilk, Peter Albers, Guido Fechner, Christian Wülfing, Hansjürgen Piechota, Tillmann Loch, Jan Lehmann, and Michael Stöckle Markus HackMarkus Hack More articles by this author , Martin GerberMartin Gerber More articles by this author , Olaf DilkOlaf Dilk More articles by this author , Peter AlbersPeter Albers More articles by this author , Guido FechnerGuido Fechner More articles by this author , Christian WülfingChristian Wülfing More articles by this author , Hansjürgen PiechotaHansjürgen Piechota More articles by this author , Tillmann LochTillmann Loch More articles by this author , Jan LehmannJan Lehmann More articles by this author , and Michael StöckleMichael Stöckle More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)37575-XAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "313: Long-Term Survival of Patients with Metastatic Transitional Cell Carcinoma Treated with a Combined-Modality Approach of Chemotherapy and Metastasectomy." The Journal of Urology, 171(4S), p. 82 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 171Issue 4SApril 2004Page: 82 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Markus Hack More articles by this author Martin Gerber More articles by this author Olaf Dilk More articles by this author Peter Albers More articles by this author Guido Fechner More articles by this author Christian Wülfing More articles by this author Hansjürgen Piechota More articles by this author Tillmann Loch More articles by this author Jan Lehmann More articles by this author Michael Stöckle More articles by this author Expand All Advertisement PDF DownloadLoading ...
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- 313: Long-Term Survival of Patients with Metastatic Transitional Cell Carcinoma Treated with a Combined-Modality Approach of Chemotherapy and Metastasectomy
- Date Crossref
- 01/04/2004
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.